study question: Does the chance of pregnancy keep improving with increasing number of oocytes, or can you collect too many? summary answer: Clinical pregnancy (CP) and live birth (LB) rates per embryo transfer varied from 10.2 and 9.2% following one oocyte collected to 37.7 and 31.3% when .16 oocytes were collected. Regression modelling indicated success rates increased or at least stayed the same with number of oocytes collected.
Introduction
The first successful IVF live births were a result of natural cycles (Steptoe and Edwards, 1978; Lopata et al., 1980) . However, the success rate of these cycles was low. This led to the utilization of stimulated cycles, which were pioneered with the use of Clomiphene Citrate (Trounson et al., 1981) , and later with FSH (Jones et al., 1982) . Controlled ovarian hyperstimulation (COH) became routine and there have been many modifications of treatment since, including the use of highly purified FSH and the use of GnRH agonists and later GnRH antagonists to inhibit ovulation.
Along with their success, stimulated cycles led to other problems, including ovarian hyper-stimulation syndrome (OHSS). It has also been suggested that the high level of estrogen in COH cycles may be detrimental to oocyte quality as well as to the endometrium. Higher doses of hormones used in stimulated cycles can produce higher yields of oocytes but it has been reported that excessive stimulation and high levels of estrogen, may compromise results. There have been several previous studies suggesting that beyond a certain number of oocytes collected the pregnancy rate in the stimulated cycle with fresh embryo transfer, starts to decline. The optimum number of oocytes varied from 13 (van der Gaast et al., 2006) , 15 to 20 (Sunkara et al., 2011) , or as wide a range as 6 to 15 (Ji et al., 2013) , whilst a study by Kok and colleagues (Kok et al., 2006) suggested that although high responders had a higher percentage of immature oocytes, the pregnancy outcome was not impaired.
The suggestion that one can have 'too many oocytes?' is anti-intuitive, as if there are more oocytes available for fertilization, there should be a higher number of embryos produced, giving greater choice for embryo transfer and a better outcome.
These studies include cycles using older stimulation protocols, and the purpose of the current study was to investigate if their conclusions remain true for more modern stimulation protocols and with the evolution of delayed transfer at the blastocyst stage.
We therefore carried out a retrospective analysis of clinical pregnancy and live birth outcome, with respect to number of oocytes collected.
Materials and Methods
Our retrospective study looked at women treated in stimulated cycles at Monash IVF for the 2-year period between August 2010 and July 2012, where the patient underwent a fresh embryo transfer. This included 7697 stimulated cycles for IVF and ICSI. Exclusion criteria comprised, cycles in which no oocytes were collected (96), no oocyte fertilized (675), all embryos were frozen (44) to avoid OHHS, the patient was an oocyte donor, or the oocyte collection was performed when the woman was aged 45 years or over (29 cycles in 25 women only one of whom had a baby). To estimate the impact of embryo cryopreservation, results for all patients aged ,45 using their own frozen embryos in the same time-period (August 2010 and July 2012) were analysed. This included some patients in the fresh embryo transfer group above and other patients but excluded those using donated oocytes or embryos. A total of 7257 embryos were thawed, 5807 were transferred in 5352 procedures, 1384 were discarded because they were no longer required by the patient or failed to survive and 66 were refrozen.
We extracted the data from the Monash IVF Patient Management System (PMS), and then analysed it using Microsoft Excel and Genstat. Clinical pregnancy (CP) was defined as a fetal heart visualized on ultrasound scan at between 6 and 7 weeks gestation, and a live birth (LB) was defined as one or more live babies delivered beyond 20 weeks of gestation. Factors potentially influencing pregnancy and birth rates after IVF and ICSI were also retrieved including female age, fertilization rate, number and stage of embryos transferred, number of previous ART treatments and a previous birth from ART (Baker et al., 2000) , ovarian stimulation by agonist or antagonist protocols and BMI of the women.
To facilitate statistical analysis, data tables were constructed, of numbers of CP and LB by oocyte numbers in different subgroups, and these results were plotted on graphs with exact 95% confidence limits for proportions. In order to have sufficient numbers for tabulation and graphing oocyte numbers were grouped as indicated in the figure and table legends. Age was grouped as: under 35, 35 -39 and over 40. As the study includes some women who have had previous treatments, and some of the women had several cycles within the study period, regression modelling was done in two ways. First, the 3600 patients who had their first oocyte collection with an embryo transfer within the reference period were analysed by logistic regression analysis, including the explanatory variables for CP and LB rates. With age as a continuous variable with no effect up to age 35 (ages below 35 were recoded to 35), fertilization rate (proportion of oocytes collected which fertilized normally), blastocyst (Day 5 or 6) or cleavage stage transfer (Day 2 -4), the number of embryos transferred (one or two), and the number of oocytes collected, log transformed because of skewed distribution. The second analysis involved all the 7697 oocyte collections with fresh embryo transfers. We used generalized estimating equations (GEE) with exchangeable correlation structure and sandwich estimation of standard errors to allow for the within subject correlation in outcomes for repeated treatments, using the above covariates and previous birth from ART and oocyte collection number log transformed because of skewness. Parsimonious models with only those factors usually statistically significant are reported. As some factors such as age and blastocyst transfer are related to both number of oocytes collected and the pregnancy outcome, the significance of possible interactions between them was tested.
As no identifying data were used, institutional ethics committee approval was not required. The study was approved by the Monash IVF Research Committee.
Results
The number of oocytes collected varied from 1 to 48. CP rate per embryo transfer varied from 10.2% when only one oocyte was collected to 37.7% when .16 oocytes were collected. LB rate per embryo transfer varied from 9.2% following collection of 1 oocyte to 31.3% following collection of .16 oocytes. The rates of both of these outcomes increased as the number of oocytes collected increased but there was considerable scatter about the trend both for all the cycles (Fig. 1 ) and for first oocyte collections (Table I ). The effects of age and blastocyst transfer are shown in Figs 2 and 3. In this data set stimulation protocol and BMI had no significant association with CP or LB rates and are not reported separately.
To allow for the other factors, which affect pregnancy rates, logistic regression analysis was performed on the results for women having their Pregnancy rate increases with oocyte numbers first oocyte collection. There was no evidence of a decline in the CP or LB rates with oocyte number, there being weakly significant (P , 0.05) upward trends with log oocyte number (Table II) . There were no significant interactions between age and oocyte number or blastocyst transfer and oocyte number on the outcomes. Table III shows the effects of age group and blastocyst transfer on CP and LB. The upward trend CP and LB with oocyte number is only clear in the 30-to 34-year age group.
When all 7697 cycles were analysed by GEE, oocyte collection number and previous ART birth were also significantly related to pregnancy rates and there was a more significant increase in both CP and LB with log oocyte number (Table IV) . There were no significant interactions between age and oocyte number or blastocyst transfer and oocyte number on the outcomes. We also examined the relationship between oocyte immaturity and number of oocytes collected in those patients who had ICSI and confirmed a significant upward trend (P , 0.001) to 22% in those with .16 oocytes collected (Table V) .
The proportion of women with embryos cryopreserved and the average numbers of embryos frozen increased markedly with the number of oocytes collected. Patients aged ,45 using their own frozen embryos in the same time (August 2010 and July 2012) had 1658 clinical pregnancies (31% per transfer) and 1299 births (24% per transfer). The birth rate per thawed embryo was 18% (1299/7257). These figures were used to calculate the potential number of extra births from use of frozen embryos in Table V Pregnancy rate increases with oocyte numbers treatments were only 0.6% of the total they were 1.2% of those with 10 or more oocytes collected (Table V) and the frequency of freeze all increased with the number of oocytes collected (.16, 2.6%, .20, 3.0%, .24 6.7%, .28 11.7%).
Discussion
Our findings suggest that pregnancy and live birth rates do not decrease with increasing numbers of eggs collected, so as long as there is not OHSS, you cannot collect too many oocytes. OHSS is the most common serious complication of COH, with potentially fatal complications of venous thrombo-embolism, or arterial thrombosis (usually cerebral) (Kasum et al., 2014) . The type of OHSS associated with multiple follicles and the collection of many oocytes is referred to as 'early phase' and usually occurs within 9 days of hCG administration. With the use of the GnRH antagonist protocols for COH, and the option of using a GnRH agonist for final oocyte maturation, the use of hCG can be omitted, and the risk of significant OHSS is virtually eliminated (Alama et al., 2013) . This therefore reduces the risk of OHSS associated with collecting many oocytes. The graphs indicate a curvilinear relationship with steep rise in pregnancy rates with 1-3 oocytes collected and a tendency to flatten after 15 oocytes. Regression modelling suggests a continued logarithmic increase with oocyte number, particularly when all cycles were analysed, but this was less significant when only 'first cycles' were considered. As the data become sparse above 15 oocytes, we could not demonstrate a significant increase in pregnancy rates above this number because the lack of statistical power means that there is great uncertainty. Larger studies would be required to answer the question whether there is a plateau, or rates continue to increase. The results do refute the proposition of a decline in pregnancy and live birth rates from fresh transfers after collection of large numbers of oocytes. Kok and colleagues made the point that although the pregnancy rate is not impaired as oocytes numbers increase, the proportion of immature oocytes increased (Kok et al., 2006) . We show a similar but less steep rise in immature oocytes. Despite this, the proportion of women having embryos cryopreserved, the average number of embryos frozen and calculated potential births from these increase dramatically with higher numbers of oocytes collected.
Monash IVF transfer policy over this period has been that women, with four or more oocytes fertilized, are advised to undergo a blastocyst transfer whereas with three or less transfer at the cleavage stage is recommended. This is why there are no blastocyst transfers for women who only had one oocyte collected. Following this policy, women who have a large number of oocytes are unlikely to undergo a cleavage stage transfer and that is why there are no data for cleavage stage transfer when .20 oocytes were collected.
For those cycles where a large number of oocytes were associated with significant clinical OHSS, no embryo transfer occurred for safety reasons. As a result, these cycles were excluded from analysis even though many would have achieved a pregnancy, as a result of subsequent frozen embryo transfer (Maheshwari and Bhattacharya, 2013) . Often when there was concern about OHSS, an agonist trigger (nafarelin acetate, two sniffs) was used to achieve follicular maturation. Because of the negative effect on the endometrium, these cycles became 'freeze all' cycles, where no fresh embryo transfer was undertaken.
We did not investigate the cause of subfertility, as all patients were already undergoing IVF or ICSI and the reason for treatment is not relevant with respect to this study.
Conclusion
The results of this study suggest that you cannot collect too many oocytes as both clinical pregnancy and live birth rates continue to increase as number of oocytes collected increases. Obtaining more embryos from one oocyte collection also increases the chance of cryopreservation and subsequent frozen embryo transfers and reduces the need for repeated ovarian stimulation and oocyte collections. The patient has a decreased risk of complications and a better chance of pregnancy. However, OHSS continues to be the commonest serious complication of COH and so the risk of it occurring must be considered when stimulation doses are decided.
